You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

  • Technology appraisal guidance
  • Reference number: TA238
  • Published:  14 December 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS

Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS Arthritis (juvenile idiopathic, systemic) - tocilizumab: Roche comments on ACD - erratum PSA for PAS
27 October 2011
(229.78 Kb 6 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 October 2011

Back to top